This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04404/identifier/pubchem-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04404/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04404/identifier/drugbank/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04404/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB04404/identifier/pdb/

Statements

Subject Item
n2:DB04404
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB04404 n10:DB04404
dcterms:title
Allosamizoline
adms:identifier
n4:AMI n9:2011 n11:46936968 n12:46504658 n14:DB04404
n5:IUPAC-Name
n6:271B56DE-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B56E4-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B56E3-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B56E0-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B56E1-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B56E2-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B56DC-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B56DA-363D-11E5-9242-09173F13E4C5 n6:271B56DD-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B56DB-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B56EA-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B56EB-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B56E5-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B56E6-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B56E8-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B56E7-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B56E9-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B56F0-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B56F2-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B56F3-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B56EF-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B56EE-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B56F1-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B56DF-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B56EC-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B56ED-363D-11E5-9242-09173F13E4C5